News

The transaction with Biovail includes a purchase price of $10m and additional payments of up to $1.5m based upon defined clinical development milestones. The agreement entails the transfer

The study enrolled healthy volunteers 18 to 49 years in age who were immunized with a single injection of Novavax’s trivalent seasonal influenza VLP vaccine matched to the

As a result of the approval, Erbitux can now be used in Japan in combination with chemotherapy in the first-line-treatment for patients with epidermal growth factor receptor (EGFR)-expressing,

Under terms of the agreement, Procaps will be responsible for obtaining regulatory and pricing approval in Colombia, South America. Procaps also will be responsible for the vial filling,

The project is undertaken jointly by NCBS, Stanford University and Technical University of Denmark. VLife Sciences Technologies said that the project involves studying coiled coil interactions in proteins

BioClinica said that with this acquisition, it has enhanced its ability to serve customers throughout the clinical research process with technologies that include improved efficiencies by reducing study

Keyrus Biopharma has gained flexibility in designing clinical trials and managing data collection, as well as increased scalability to support business expansion, with Oracle Clinical. The solution provides

Discovered and developed by Eisai, Eritoran is believed to block activation of toll-like receptor 4 (TLR4). TLR4 is part of the innate immune system and, when it is

Access Pharmaceuticals said that MuGard is ready-to-use mucoadhesive oral wound rinse and coating for the management of oral mucositis, a debilitating side effect of many anticancer treatments. As